Hanall Biopharma Co.,Ltd (009420.KS) KSC

56,700.00

-1400(-2.41%)

Updated at June 02 03:30PM

Currency In KRW

Hanall Biopharma Co.,Ltd

Address

Daewoong Building

Daejeon,

Korea (the Republic of)

Phone

+82 2 6440 7000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

309

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Su-Jin ParkCo-CEO, VP & Director01972
Sean JeongPresident, Co-CEO & Director01971
SeongUn KimHead of Business Management Division01980
Hye Kyung AhnHead of Research Division01971
Nam-Yong ChoSenior Executive Director of Sales & Marketing and Senior Managing Director01954
Christopher W. SlavinskyChief Business Development & Legal Officer01973
Jae-Seung YoonC.V.O01962

Description

Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.